We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
C4x Discovery Holdings Plc | LSE:C4XD | London | Ordinary Share | GB00BQQ2RV18 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 12.00 | 10.30 | 10.80 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 1.71M | -11.11M | -0.0441 | -2.72 | 30.27M |
Date | Subject | Author | Discuss |
---|---|---|---|
09/7/2020 22:13 | U mean the biggest PI holder on here !! | amaretto1 | |
09/7/2020 22:09 | Oh the big brave keyboard warrior is back lol | alloa2003 | |
09/7/2020 08:25 | Absolute rubbish - as and when C4XD receive a milestone payment they will need to announce it to the market. On such a small market cap any payment could be deemed significant. Why on earth would they negotiate and announce the fact there were milestone payments if they werent going to announce them? The milestone payments will be set in stone - when "x happens you receive a payment." on a stage by stage basis. The legal action by the US government has no bearing on the C4XD deal, in fact it would be in the best interests of INDV to announce a medication which helps with the opioids problem which is exactly what the C4XD molecule does. | alloa2003 | |
09/7/2020 08:18 | They can still hide it. This has come as a post balance sheet event. | the stigologist | |
09/7/2020 07:46 | Full Year results end July so there will be no hiding ! | golden prospect | |
08/7/2020 23:17 | are you sure for a listed company? what happens when say a mystery £5million appears in the accounts? They can keep the milestones secret until one is achieved and a payment is made. | davemac3 | |
08/7/2020 23:13 | No. You do not have to RNS if it would affect your business because it's a major strategic relationship governed by separate contractual NDA. | the stigologist | |
08/7/2020 22:41 | It would be a material event and would have to be RNSed by C4X | davemac3 | |
08/7/2020 20:31 | These things are normally subject to NDAs anyway But obviously complicated in this particular case by INDV issues with DoJ | the stigologist | |
08/7/2020 15:56 | It doesn't seem right that shareholders don't know whether a milestone payment is due from Indivior for start of Phase 1. | davemac3 | |
08/7/2020 10:51 | Ah, thanks for the info! | devonlad | |
08/7/2020 10:44 | Went from 60p to 120p when they announced deal in March 2018 2+ years on INDV will be desperate for this to work Despite being in a lawsuit against US Government the US Government are funding Phase I and II to tune of $10m C4X I am sure would love to promote it but they have to wait for INDV to RNS/publicise I suspect | the stigologist | |
08/7/2020 10:40 | Just need to clear the seller, you would have thought they would RNS that given the lack of newsflow. Still very much under the radar. | devonlad | |
08/7/2020 10:15 | I looked at some public domain milestones for Phase I and they seemed to be in the range of $4-10m That would be huge for a £16m Mkt Cap Company in terms of both FINANCE and VALIDATION | the stigologist | |
08/7/2020 09:52 | Actual study start date = 6th July so milestone payment is possible | golden prospect | |
08/7/2020 09:14 | Potentially huge news for C4XD £16m Mkt Cap they could be due significant milestone on this | the stigologist | |
08/7/2020 08:03 | Now recruiting, excellent news 7th July 2000 | golden prospect | |
03/7/2020 14:46 | You have such a professional and welcoming turn of phrase (clap clap) | alloa2003 | |
01/7/2020 16:49 | Lets try another term you might understand Lowgrader - market/price manipulation. The constant posting of scare stories and/or speculation which might influence others. That better? | alloa2003 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions